Lexaria Bioscience Corp. — Director's Dealing 2015

Oct 21, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-19	Common Shares	P	1500	$0.19	Acquired	5901196	Direct
2015-10-20	Common Shares	P	5000	$0.19	Acquired	5906196	Direct
2015-10-20	Common Shares	P	10400	$0.185	Acquired	5916596	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	5899696	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Common Shares	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2017-05-15	Common Shares (170000)	170000	Indirect